The committees on CIM and Pediatric Otolaryngology have identified this as an area of importance and asked us to present it to the otolaryngology community. There are new recommendations from the GI community against empiric use of PPIs in young children and there is a blackbox warning against the use of zantac. There is also mounting evidence of improved outcomes with nutritional and dietary modification for common pediatric otolaryngology ailments including reflux, sinusitis, chronic cough and laryngomalacia. These issues are often discussed in the pediatric Aerodigestive societies and need to be presented for the general otolaryngology community as they are less “alternative” and quickly becoming standard of care.